​The IRSN has obtained funding from the American national agency for health and biomedical research (NIH - National Institutes of Health) for a one-year pilot project on the "Evaluation of the therapeutic effects of exosomes in the gastro-intestinal syndrome".

The aim of this project is to extend the research conducted by IRSN's Research laboratory in irradiated healthy tissue regeneration (LR2I) to new therapeutic approaches based on the use of stem cells to treat lesions induced by high doses of ionizing radiation.

More information